eMTBR-Tau243 is an emerging biomarker that may provide deeper insight into tau aggregation and Alzheimer’s disease progression. Unlike upstream markers such as pTau-217, eMTBR-Tau243 may better reflect downstream tau pathology and neurodegeneration. A sensitive blood-based assay could support disease staging, longitudinal monitoring, and therapeutic response assessment.